Company Filing History:
2 out of 48 
2 out of 119 
Years Active: 2013-2016
Title: Achim Krueger: Innovator in Tumor Treatment
Introduction
Achim Krueger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of tumors. With a focus on innovative therapies, Krueger has been instrumental in developing new approaches to combat cancer.
Latest Patents
Achim Krueger holds 2 patents related to his groundbreaking work. His latest patents include the treatment of tumors using a specific anti-L1 antibody. The present invention relates to the anti-L1 monoclonal antibody 9.3, as well as to related antibodies or binding molecules, and their uses, especially in tumor treatment.
Career Highlights
Throughout his career, Krueger has worked with prominent organizations in the medical field. He has been associated with Medigene AG and the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Achim Krueger has collaborated with esteemed colleagues, including Daniela Kelm and Peter Altevogt. These partnerships have fostered a collaborative environment that enhances innovation and research in tumor treatment.
Conclusion
Achim Krueger's contributions to the field of tumor treatment through his patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future innovations in cancer therapy.